Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 4635K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Jiang, Y. Articles by Kang, Y. J. Search for Related Content PubMed PubMed Citation Articles by Jiang, Y. Articles by Kang, Y. J. Related Collections Related Article Social Bookmarking                            What's this?

¹ Department of Medicine, ² Department of Physiology and Biophysics, and ⁴ Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville KY 40202
³ U.S. Department of Agriculture Human Nutrition Research Center Grand Forks, ND 58202

CORRESPONDENCE Y. James Kang: yjkang01{at}louisville.edu

Sustained pressure overload causes cardiac hypertrophy and the transition to heart failure. We show here that dietary supplementation with physiologically relevant levels of copper (Cu) reverses preestablished hypertrophic cardiomyopathy caused by pressure overload induced by ascending aortic constriction in a mouse model. The reversal occurs in the continued presence of pressure overload. Sustained pressure overload leads to decreases in cardiac Cu and vascular endothelial growth factor (VEGF) levels along with suppression of myocardial angiogenesis. Cu supplementation replenishes cardiac Cu, increases VEGF, and promotes angiogenesis. Systemic administration of anti-VEGF antibody blunts Cu regression of hypertrophic cardiomyopathy. In cultured human cardiomyocytes, Cu chelation blocks insulin-like growth factor (IGF)-1– or Cu-stimulated VEGF expression, which is relieved by addition of excess Cu. Both IGF-1 and Cu activate hypoxia-inducible factor (HIF)-1 and HIF-1 gene silencing blocks IGF-1– or Cu-stimulated VEGF expression. HIF-1 coimmunoprecipitates with a Cu chaperone for superoxide dismutase-1 (CCS), and gene silencing of CCS, but not superoxide dismutase-1, prevents IGF-1– or Cu-induced HIF-1 activation and VEGF expression. Therefore, dietary Cu supplementation improves the condition of hypertrophic cardiomyopathy at least in part through CCS-mediated HIF-1 activation of VEGF expression and angiogenesis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related Article

Heavy metal for a troubled heart

Hema Bashyam
J. Exp. Med. 2007 204: 455a. [Full Text] [PDF]

This article has been cited by other articles:

• Zhou, Y., Bourcy, K., Kang, Y. J. (2009). Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway. Cardiovasc Res 84: 54-63 [Abstract] [Full Text]  
• Bousquet-Moore, D., Ma, X. M., Nillni, E. A., Czyzyk, T. A., Pintar, J. E., Eipper, B. A., Mains, R. E. (2009). Reversal of Physiological Deficits Caused by Diminished Levels of Peptidylglycine {alpha}-Amidating Monooxygenase by Dietary Copper. Endocrinology 150: 1739-1747 [Abstract] [Full Text]  
• Makino, A., Suarez, J., Wang, H., Belke, D. D., Scott, B. T., Dillmann, W. H. (2009). Thyroid Hormone Receptor-{beta} Is Associated with Coronary Angiogenesis during Pathological Cardiac Hypertrophy. Endocrinology 150: 2008-2015 [Abstract] [Full Text]  
• Feng, W., Ye, F., Xue, W., Zhou, Z., Kang, Y. J. (2009). Copper Regulation of Hypoxia-Inducible Factor-1 Activity. Mol. Pharmacol. 75: 174-182 [Abstract] [Full Text]  
• Song, M., Song, Z., Barve, S., Zhang, J., Chen, T., Liu, M., Arteel, G. E., Brewer, G. J., McClain, C. J. (2008). Tetrathiomolybdate Protects against Bile Duct Ligation-Induced Cholestatic Liver Injury and Fibrosis. J. Pharmacol. Exp. Ther. 325: 409-416 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS